Congress

Lamar Alexander 340B
Politics

Key lawmaker calls for more scrutiny of hospitals using drug discount program — but no broader changes

By Erin Mershon

Chuck Grassley CREATES
Politics

Bill to encourage generic-drug development passes a key hurdle

By Erin Mershon

Pharmalot

Pharmalittle: Feds fight bid to disclose opioid shipments; Allergan moves to appease critics

By Ed Silverman

Paul Ryan, Kevin McCarthy, Greg Walden
Politics

Major opioids legislation is taking shape. Can it make a dent in a national epidemic?

By Lev Facher

Prescription benefit managers
Politics

FDA broadens guidelines on what information drug makers can share with insurers

By Ike Swetlitz

Alex Azar Senate Health Committee
Politics

Drug makers considering ‘substantial’ decreases in prices, Azar says

By Ike Swetlitz and Erin Mershon

Pharma

Drug pricing advocates take aim at Democrats for supporting pharma

By Erin Mershon

Opioid Lobbying
Politics

As opioids legislation gains steam, efforts to address crisis collide with moneyed interests

By Lev Facher

Antibiotics Pharmacy
Politics

Lawmakers advocate for new antibiotics, but stop short of offering incentives

By Ike Swetlitz

Pharmalot

Pharmalittle: Philippine official blames deaths on Sanofi dengue vaccine; Pfizer wants you to know it still invests in neuroscience

By Ed Silverman

Pharmalot

Swiss attorney general will not pursue bribery charges against Novartis for payments to Trump lawyer

By Ed Silverman

Generic Drug Production
Politics

Momentum grows to resurrect legislation aimed at bringing generic drugs to market faster

By Erin Mershon

Opioid Prescriptions
Politics

FDA targets websites illegally marketing opioids — and presses tech giants to step up

By Lev Facher and Ike Swetlitz

Ron Johnson FDA
Politics

‘Right-to-try’ law intended to weaken the FDA, measure’s sponsor says in blunt remarks

By Erin Mershon

Politics

Senator, blocking subpoena of Teva in opioids probe, says matter should be left to courts

By Lev Facher

Pharmalot

Pharmalittle: A battered Celgene does a big stock buyback; Senate committee to vote on pharmacy gag clause bill

By Ed Silverman

Antibiotics IV
Politics

Effort to encourage development of new antibiotics falls short in Senate

By Ike Swetlitz

Pharmalot

Pharmalittle: Insys execs claim feds made ‘ugly insinuations’; just how many Pfizer drugs are in short supply?

By Ed Silverman

Kevin McCarthy Speaks
Health

Congress passes ‘right-to-try’ measure, sending hard-fought bill to Trump’s desk

By Erin Mershon

Pharmalot

Pharmalittle: Roche hemophilia drug gets a boost; lawmaker challenges Trump on plan to use trade to lower prices

By Ed Silverman

ACA Repeal
Politics

Ryan touts CREATES Act ‘compromise’ as part of congressional work on drug prices

By Erin Mershon

Dr. Scott Gottlieb,
Politics

Right-to-try bill headed for vote puts bigger burden on FDA to protect patients, Gottlieb says

By Ike Swetlitz and Erin Mershon

Lamar Alexander 340 B
Politics

Taking aim at 340B drug program, lawmakers target both hospitals and pharma

By Erin Mershon

Alex Azar
Politics

From drug ads to Medicare moves, 5 policy takeaways from Trump’s drug pricing speech

By Ike Swetlitz, Erin Mershon, and Lev Facher

Democrat Drug Price Rebuttal
Politics

Democrats offer a counterpoint to Trump’s drug pricing policy before major speech

By Erin Mershon

Patrick Morrisey
Politics

A contentious West Virginia Senate race pits two candidates with close ties to pharma

By Lev Facher

Opioid Hearing
Politics

Congressman to drug distributors: ‘I just want you to feel shame’

By Lev Facher

Prescription opioid
Politics

Drug distributors get hauled to the Hill to face questions on opioids

By Lev Facher

DHART
First Opinion

Placing more regulations on air medical services would be bad for patients

By Richard Sherlock

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy